ESMO-ASCO joint statement to UN hearing on non-communicable diseases


  • Dawn O'Shea
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO) have issued a joint statement calling for “strong political and financial commitment to pass legislation and invest in actions” to reduce the burden of non-communicable diseases (NCDs).

The statement was issued to coincide with the United Nations (UN) Civil Society Hearing on NCDs in New York last week.

It proposes changes to the Draft Elements Paper for a Political Declaration which will be considered at the upcoming High-Level Meeting of the UN General Assembly on the Prevention and Control of NCDs. Among the proposed changes is that the Declaration includes an assurance of access to vaccines for all people and all stages of disease, even advanced/metastatic disease.

The organisations call on Heads of State and Health Ministers to reconfirm their commitment to reduce premature mortality from cancer by 25 per cent by 2025, as called for in the WHO Global Action Plan on NCDs, and by 33 per cent by 2030, as called for by the 2030 UN Sustainable Development Goals.

“It is imperative that we act now before we are overwhelmed with a tsunami of future cancer cases that will drain our health systems and our economies,” they warn.